Oppenheimer & CO Inc Heron Therapeutics, Inc. Transaction History

Oppenheimer & CO Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$14.49 - $20.72 $157,941 - $225,848	-10,900 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$14.61 - $22.14 $27,759 - $42,066	-1,900 Reduced 14.84%	10,900 $231,000
Q3 2020 Nov 13, 2020	SELL	$13.67 - $17.77 $27,340 - $35,540	-2,000 Reduced 13.51%	12,800 $190,000
Q2 2020 Aug 11, 2020	SELL	$10.89 - $21.47 $87,120 - $171,760	-8,000 Reduced 35.09%	14,800 $218,000
Q3 2019 Oct 31, 2019	SELL	$16.36 - $21.39 $17,996 - $23,529	-1,100 Reduced 4.6%	22,800 $422,000
Q2 2019 Aug 09, 2019	SELL	$16.93 - $26.22 $135,440 - $209,760	-8,000 Reduced 25.08%	23,900 $444,000
Q1 2019 Apr 24, 2019	SELL	$23.15 - $28.34 $359,426 - $440,006	-15,526 Reduced 32.74%	31,900 $780,000
Q4 2018 Jan 29, 2019	SELL	$22.03 - $32.01 $198 - $288	-9 Reduced 0.02%	47,426 $1.23 Million
Q3 2018 Oct 26, 2018	BUY	$30.0 - $40.85 $285,600 - $388,892	9,520 Added 25.11%	47,435 $1.5 Million
Q2 2018 Aug 10, 2018	SELL	$26.4 - $42.0 $157,977 - $251,328	-5,984 Reduced 13.63%	37,915 $1.47 Million
Q1 2018 May 01, 2018	BUY	$18.43 - $28.8 $809,058 - $1.26 Million	43,899 New	43,899 $1.21 Million

172

114M

32.4K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $219M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.